<rdf:RDF xmlns:api="http://www.elsevier.com/xml/svapi/rdf/dtd/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77954651554"><dc:identifier>https://api.elsevier.com/content/abstract/eid/2-s2.0-77954651554</dc:identifier><api:scopusId>77954651554</api:scopusId><api:eid>2-s2.0-77954651554</api:eid><api:pubmedId>20647199</api:pubmedId><api:pui>359181047</api:pui><api:pii>S0028479314654411</api:pii><prism:doi>10.1056/NEJMoa0909905</prism:doi><dc:title>Rituximab versus cyclophosphamide for ANCA-associated vasculitis</dc:title><prism:issn>15334406</prism:issn><prism:issn>00284793</prism:issn><prism:contentType>Abstract</prism:contentType><prism:aggregationType>Journal</prism:aggregationType><api:srctype>j</api:srctype><api:subtype>ar</api:subtype><api:subtypeDescription>Article</api:subtypeDescription><api:citedbyCount>1165</api:citedbyCount><prism:publicationName>New England Journal of Medicine</prism:publicationName><dc:publisher> Massachussetts Medical Society </dc:publisher><api:sourceId>15847</api:sourceId><prism:volume>363</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:startingPage>221</prism:startingPage><prism:endingPage>232</prism:endingPage><prism:pageRange>221-232</prism:pageRange><prism:coverDate>2010-07-15</prism:coverDate><prism:copyrightYear>2010</prism:copyrightYear><dc:creator><rdf:Seq><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7403061301"><api:authid>7403061301</api:authid><api:surname>Stone</api:surname><api:givenName>John H.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60029929"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005329470"><api:authid>7005329470</api:authid><api:surname>Merkel</api:surname><api:givenName>Peter A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60003526"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6603891428"><api:authid>6603891428</api:authid><api:surname>Spiera</api:surname><api:givenName>Robert</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60022875"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7004565460"><api:authid>7004565460</api:authid><api:surname>Seo</api:surname><api:givenName>Philip</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005248"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7102621970"><api:authid>7102621970</api:authid><api:surname>Langford</api:surname><api:givenName>Carol A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60021160"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7202530752"><api:authid>7202530752</api:authid><api:surname>Hoffman</api:surname><api:givenName>Gary S.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60021160"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/35395889100"><api:authid>35395889100</api:authid><api:surname>Kallenberg</api:surname><api:givenName>Cees G.M.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60010023"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/9040344800"><api:authid>9040344800</api:authid><api:surname>William St Clair</api:surname><api:givenName>E.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60008724"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/8713817500"><api:authid>8713817500</api:authid><api:surname>Turkiewicz</api:surname><api:givenName>Anthony</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60027086"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6506358506"><api:authid>6506358506</api:authid><api:surname>Tchao</api:surname><api:givenName>Nadia K.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/100999245"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/36341914000"><api:authid>36341914000</api:authid><api:surname>Webber</api:surname><api:givenName>Lisa</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60017336"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/56391513500"><api:authid>56391513500</api:authid><api:surname>Ding</api:surname><api:givenName>Linna</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60017336"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/13407734400"><api:authid>13407734400</api:authid><api:surname>Sejismundo</api:surname><api:givenName>Lourdes P.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005248"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/15042708700"><api:authid>15042708700</api:authid><api:surname>Mieras</api:surname><api:givenName>Kathleen</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6603183465"><api:authid>6603183465</api:authid><api:surname>Weitzenkamp</api:surname><api:givenName>David</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/109248104"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7004316017"><api:authid>7004316017</api:authid><api:surname>Ikle</api:surname><api:givenName>David</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/109248104"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/10439377300"><api:authid>10439377300</api:authid><api:surname>Seyfert-Margolis</api:surname><api:givenName>Vicki</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/100999245"/><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60010237"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/36340642000"><api:authid>36340642000</api:authid><api:surname>Mueller</api:surname><api:givenName>Mark</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/100999245"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/55393240900"><api:authid>55393240900</api:authid><api:surname>Brunetta</api:surname><api:givenName>Paul</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60026209"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7202441979"><api:authid>7202441979</api:authid><api:surname>Allen</api:surname><api:givenName>Nancy B.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60008724"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6701686142"><api:authid>6701686142</api:authid><api:surname>Fervenza</api:surname><api:givenName>Fernando C.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/22953320400"><api:authid>22953320400</api:authid><api:surname>Geetha</api:surname><api:givenName>Duvuru</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005248"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6602502450"><api:authid>6602502450</api:authid><api:surname>Keogh</api:surname><api:givenName>Karina A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6701848064"><api:authid>6701848064</api:authid><api:surname>Kissin</api:surname><api:givenName>Eugene Y.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60003526"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6603256283"><api:authid>6603256283</api:authid><api:surname>Monach</api:surname><api:givenName>Paul A.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60003526"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/6603395824"><api:authid>6603395824</api:authid><api:surname>Peikert</api:surname><api:givenName>Tobias</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005622095"><api:authid>7005622095</api:authid><api:surname>Stegeman</api:surname><api:givenName>Coen</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60010023"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7003494524"><api:authid>7003494524</api:authid><api:surname>Ytterberg</api:surname><api:givenName>Steven R.</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li><rdf:li><api:Author rdf:about="https://api.elsevier.com/content/author/author_id/7005264715"><api:authid>7005264715</api:authid><api:surname>Specks</api:surname><api:givenName>Ulrich</api:givenName><api:affiliation rdf:resource="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"/></api:Author></rdf:li></rdf:Seq></dc:creator><dc:subject rdf:resource="http://data.elsevier.com/vocabulary/ASJC/2700"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0028158243"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/34250840592"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0026505235"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033050247"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0034044534"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0043074578"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0015244186"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0015764397"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/70449213796"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0038122889"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/12544253745"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/22244469119"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/33646477546"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/51849091965"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/2442433618"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0033065098"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0018869708"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0020051506"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0023268764"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0037297117"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035674612"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/12344330217"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/31944440872"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/77954632414"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0035053927"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0031042957"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0032212679"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/21244459947"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/3242881591"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/0020570938"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/36348939350"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/18144382238"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/58149180323"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/23644455521"/><api:reference rdf:resource="https://api.elsevier.com/content/abstract/scopus_id/66149168812"/><api:article rdf:resource="https://api.elsevier.com/content/article/eid/1-s2.0-S0028479314654411"/><api:scopusPage rdf:resource="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=77954651554&amp;origin=inward"/></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60029929"><api:afid>60029929</api:afid><skos:prefLabel>Massachusetts General Hospital</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60003526"><api:afid>60003526</api:afid><skos:prefLabel>Boston Medical Center</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60022875"><api:afid>60022875</api:afid><skos:prefLabel>Hospital for Special Surgery - New York</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60005248"><api:afid>60005248</api:afid><skos:prefLabel>Johns Hopkins University</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60021160"><api:afid>60021160</api:afid><skos:prefLabel>Cleveland Clinic Foundation</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60010023"><api:afid>60010023</api:afid><skos:prefLabel>University of Groningen</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60008724"><api:afid>60008724</api:afid><skos:prefLabel>Duke University</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60027086"><api:afid>60027086</api:afid><skos:prefLabel>University of Alabama at Birmingham</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/100999245"><api:afid>100999245</api:afid><skos:prefLabel>Immune Tolerance Network</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60017336"><api:afid>60017336</api:afid><skos:prefLabel>National Institute of Allergy and Infectious Diseases</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60010237"><api:afid>60010237</api:afid><skos:prefLabel>Food and Drug Administration</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60005558"><api:afid>60005558</api:afid><skos:prefLabel>Mayo Clinic</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/109248104"><api:afid>109248104</api:afid><skos:prefLabel>Rho</skos:prefLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/affiliation/affiliation_id/60026209"><api:afid>60026209</api:afid><skos:prefLabel>Genentech Incorporated</skos:prefLabel></rdf:Description><rdf:Description rdf:about="http://data.elsevier.com/vocabulary/ASJC/2700"><api:code>2700</api:code><api:abbrev>MEDI</api:abbrev><skos:prefLabel>Medicine (all)</skos:prefLabel><skos:altLabel>Medicine</skos:altLabel></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0028158243"><api:scopusId>0028158243</api:scopusId><dc:title>Nomenclature of systemic vasculitides: The proposal of an international consensus conference</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1994</prism:publicationYear><prism:volume>37</prism:volume><prism:startingPage>187</prism:startingPage><prism:endingPage>192</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/34250840592"><api:scopusId>34250840592</api:scopusId><dc:title>ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis</dc:title><prism:publicationName>Am J Med</prism:publicationName><prism:publicationYear>2007</prism:publicationYear><prism:volume>120</prism:volume></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0026505235"><api:scopusId>0026505235</api:scopusId><dc:title>Wegener granulomatosis: An analysis of 158 patients</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1992</prism:publicationYear><prism:volume>116</prism:volume><prism:startingPage>488</prism:startingPage><prism:endingPage>498</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033050247"><api:scopusId>0033050247</api:scopusId><dc:title>Microscopic polyangiitis: Clinical and laboratory findings in eighty- Five patients</dc:title><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>42</prism:volume><prism:startingPage>421</prism:startingPage><prism:endingPage>430</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0034044534"><api:scopusId>0034044534</api:scopusId><dc:title>An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients</dc:title><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><prism:publicationYear>2000</prism:publicationYear><prism:volume>43</prism:volume><prism:startingPage>1021</prism:startingPage><prism:endingPage>1032</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0043074578"><api:scopusId>0043074578</api:scopusId><dc:title>Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's Granulomatosis Etanercept Trial</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>48</prism:volume><prism:startingPage>2299</prism:startingPage><prism:endingPage>2309</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0015244186"><api:scopusId>0015244186</api:scopusId><dc:title>Cyclophosphamide therapy in Wegener's granulomatosis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>1971</prism:publicationYear><prism:volume>284</prism:volume><prism:startingPage>938</prism:startingPage><prism:endingPage>942</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0015764397"><api:scopusId>0015764397</api:scopusId><dc:title>Wegener's granulomatosis: Studies in eighteen patients and a review of the literature</dc:title><prism:publicationName>Medicine</prism:publicationName><prism:publicationYear>1973</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>535</prism:startingPage><prism:endingPage>561</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/70449213796"><api:scopusId>70449213796</api:scopusId><dc:title>Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)</dc:title><prism:publicationName>BMJ</prism:publicationName><prism:publicationYear>1958</prism:publicationYear><prism:volume>2</prism:volume><prism:startingPage>265</prism:startingPage><prism:endingPage>270</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0038122889"><api:scopusId>0038122889</api:scopusId><dc:title>A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies</dc:title><prism:publicationName>New England Journal of Medicine</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>349</prism:volume><prism:startingPage>36</prism:startingPage><prism:endingPage>44</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/12544253745"><api:scopusId>12544253745</api:scopusId><dc:title>Etanercept plus standard therapy for Wegener's granulomatosis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>352</prism:volume><prism:startingPage>351</prism:startingPage><prism:endingPage>361</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/22244469119"><api:scopusId>22244469119</api:scopusId><dc:title>Damage caused by Wegener's granulomatosis and its treatment: Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>2168</prism:startingPage><prism:endingPage>2178</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/33646477546"><api:scopusId>33646477546</api:scopusId><dc:title>Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>54</prism:volume><prism:startingPage>1608</prism:startingPage><prism:endingPage>1618</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/51849091965"><api:scopusId>51849091965</api:scopusId><dc:title>Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: Comparison of two independent cohorts</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2008</prism:publicationYear><prism:volume>58</prism:volume><prism:startingPage>2908</prism:startingPage><prism:endingPage>2918</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/2442433618"><api:scopusId>2442433618</api:scopusId><dc:title>Pathogenic roles of B cells in human autoimmunity: Insights from the clinic</dc:title><prism:publicationName>Immunity</prism:publicationName><prism:publicationYear>2004</prism:publicationYear><prism:volume>20</prism:volume><prism:startingPage>517</prism:startingPage><prism:endingPage>527</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0033065098"><api:scopusId>0033065098</api:scopusId><dc:title>Differential B- and T-cell activation in Wegener's granulomatosis</dc:title><prism:publicationName>J Allergy Clin Immunol</prism:publicationName><prism:publicationYear>1999</prism:publicationYear><prism:volume>103</prism:volume><prism:startingPage>885</prism:startingPage><prism:endingPage>894</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0018869708"><api:scopusId>0018869708</api:scopusId><dc:title>Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation</dc:title><prism:publicationName>Immunology</prism:publicationName><prism:publicationYear>1980</prism:publicationYear><prism:volume>39</prism:volume><prism:startingPage>391</prism:startingPage><prism:endingPage>397</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0020051506"><api:scopusId>0020051506</api:scopusId><dc:title>Suppression of human B lymphocyte function by cyclophosphamide</dc:title><prism:publicationName>J Immunol</prism:publicationName><prism:publicationYear>1982</prism:publicationYear><prism:volume>128</prism:volume><prism:startingPage>2453</prism:startingPage><prism:endingPage>2457</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0023268764"><api:scopusId>0023268764</api:scopusId><dc:title>Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells</dc:title><prism:publicationName>Journal of Clinical Investigation</prism:publicationName><prism:publicationYear>1987</prism:publicationYear><prism:volume>79</prism:volume><prism:startingPage>1082</prism:startingPage><prism:endingPage>1090</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0037297117"><api:scopusId>0037297117</api:scopusId><dc:title>The mechanisms of action of rituximab in the elimination of tumor cells</dc:title><prism:publicationName>Seminars in Oncology</prism:publicationName><prism:publicationYear>2003</prism:publicationYear><prism:volume>30</prism:volume><prism:startingPage>3</prism:startingPage><prism:endingPage>8</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035674612"><api:scopusId>0035674612</api:scopusId><dc:title>Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy</dc:title><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>2836</prism:startingPage><prism:endingPage>2840</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/12344330217"><api:scopusId>12344330217</api:scopusId><dc:title>Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis</dc:title><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>262</prism:startingPage><prism:endingPage>268</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/31944440872"><api:scopusId>31944440872</api:scopusId><dc:title>Rituximab for refractory Wegener's granulomatosis: Report of a prospective, open-label pilot trial</dc:title><prism:publicationName>American Journal of Respiratory and Critical Care Medicine</prism:publicationName><prism:publicationYear>2006</prism:publicationYear><prism:volume>173</prism:volume><prism:startingPage>180</prism:startingPage><prism:endingPage>187</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/77954632414"><api:scopusId>77954632414</api:scopusId><dc:title>Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2010</prism:publicationYear><prism:volume>363</prism:volume><prism:startingPage>211</prism:startingPage><prism:endingPage>220</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0035053927"><api:scopusId>0035053927</api:scopusId><dc:title>A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>2001</prism:publicationYear><prism:volume>44</prism:volume><prism:startingPage>912</prism:startingPage><prism:endingPage>920</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0031042957"><api:scopusId>0031042957</api:scopusId><dc:title>Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides</dc:title><prism:publicationName>Arthritis Rheum</prism:publicationName><prism:publicationYear>1997</prism:publicationYear><prism:volume>40</prism:volume><prism:startingPage>371</prism:startingPage><prism:endingPage>380</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0032212679"><api:scopusId>0032212679</api:scopusId><dc:title>Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project</dc:title><prism:publicationName>Journal of Clinical Epidemiology</prism:publicationName><prism:publicationYear>1998</prism:publicationYear><prism:volume>51</prism:volume><prism:startingPage>903</prism:startingPage><prism:endingPage>912</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/21244459947"><api:scopusId>21244459947</api:scopusId><dc:title>Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis</dc:title><prism:publicationName>J Clin Immunol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>25</prism:volume><prism:startingPage>202</prism:startingPage><prism:endingPage>208</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/3242881591"><api:scopusId>3242881591</api:scopusId><prism:publicationName>Common Terminology Criteria for Adverse Events V3.0 (CTCAE)</prism:publicationName></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/0020570938"><api:scopusId>0020570938</api:scopusId><dc:title>Assessing treatments with cyclophosphamide</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>1983</prism:publicationYear><prism:volume>98</prism:volume><prism:startingPage>1026</prism:startingPage><prism:endingPage>1027</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/36348939350"><api:scopusId>36348939350</api:scopusId><dc:title>Statistics in medicine - Reporting of subgroup analyses in clinical trials</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2007</prism:publicationYear><prism:volume>357</prism:volume><prism:startingPage>2189</prism:startingPage><prism:endingPage>2194</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/18144382238"><api:scopusId>18144382238</api:scopusId><dc:title>Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies</dc:title><prism:publicationName>Curr Opin Rheumatol</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>17</prism:volume><prism:startingPage>257</prism:startingPage><prism:endingPage>264</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/58149180323"><api:scopusId>58149180323</api:scopusId><dc:title>Azathioprine or methotrexate maintenance for ANCA-associated vasculitis</dc:title><prism:publicationName>N Engl J Med</prism:publicationName><prism:publicationYear>2008</prism:publicationYear><prism:volume>359</prism:volume><prism:startingPage>2790</prism:startingPage><prism:endingPage>2803</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/23644455521"><api:scopusId>23644455521</api:scopusId><dc:title>Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis</dc:title><prism:publicationName>Arthritis and Rheumatism</prism:publicationName><prism:publicationYear>2005</prism:publicationYear><prism:volume>52</prism:volume><prism:startingPage>2461</prism:startingPage><prism:endingPage>2469</prism:endingPage></rdf:Description><rdf:Description rdf:about="https://api.elsevier.com/content/abstract/scopus_id/66149168812"><api:scopusId>66149168812</api:scopusId><dc:title>Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: A randomized trial</dc:title><prism:publicationName>Ann Intern Med</prism:publicationName><prism:publicationYear>2009</prism:publicationYear><prism:volume>150</prism:volume><prism:startingPage>670</prism:startingPage><prism:endingPage>680</prism:endingPage></rdf:Description></rdf:RDF>